4-Chloromethcathinone
 | |
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
JSmol) | |
| Melting point | 198 °C (388 °F) |
| |
| |
4-Chloromethcathinone (also known as 4-CMC and Clephedrone) is a stimulant drug of the cathinone class that has been sold online as a designer drug.[1][2][3]
The exact pharmacology of 4-CMC is unknown, though it is probably a dopamine and serotonin releasing agent. Its chemical structure closely resembles
para-chloromethamphetamine and studies involving mice indicate that it is neurotoxic.[4]
Legality
Clephedrone is an Anlage I controlled drug in Germany.
Sweden's public health agency suggested classifying 4-Chloromethcathinone (klefedron) as illegal narcotic on June 1, 2015.[5]
As of October 2015 4-CMC is a controlled substance in China.[6]
4-CMC is considered a Schedule 1 substance in Virginia.[7]
In December 2019, the
UNODC announced scheduling recommendations placing 4-CMC into Schedule II.[8]
See also
- 3-Chloromethcathinone
- 3-Methylmethcathinone
- 4-Bromomethcathinone
- 4-Chloroamphetamine
- 4-Cl-3-MMC
- 4Cl-PVP
- 4-Ethylmethcathinone
- 4-Methylmethcathinone
- Substituted cathinone
References
- ^ "4-Chloromethcathinone". Cayman Chemical. Retrieved 5 September 2015.
- PMID 25280452.
- PMID 26890319.
- PMID 32506339.
- ^ "23 nya ämnen kan klassas som narkotika eller hälsofarlig vara" [23 new substances can be classified as narcotic drugs or substances dangerous to health]. Folkhälsomyndigheten [The Public Health Authority] (in Swedish). 1 June 2015. Retrieved 5 September 2015.
- ^ "关于印发《非药用类麻醉药品和精神药品列管办法》的通知" [Notice on Issuing the Measures for the Listing and Control of Non-Medicinal Narcotic Drugs and Psychotropic Substances] (in Chinese). China Food and Drug Administration. 27 September 2015. Archived from the original on 1 October 2015. Retrieved 1 October 2015.
- ^ "18VAC110-20-322. Placement of Chemicals in Schedule I." Commonwealth of Virginia. 2 December 2015. Retrieved 11 March 2016.
- ^ "World Health Organization recommends 12 NPS for scheduling". WHO. December 2019.